A Novel Convenient Synthesis of 1,3,4-Oxadiazol-2-ones and -thiones from N-tert-Butyldiacylhydrazines

Abstract

An attractive, novel, convenient process for the preparation of 3,5-disubstituted-3H-[1,3,4]-oxadiazol-2-ones and -thiones from the reaction of various equivalent and non-equivalent N-tert-butyldiacylhydrazines with potassium tert-butoxide followed by treatment with phosgene or thiophosgene, respectively, has been discovered. The 3,5-disubstituted-3H-[1,3,4]-oxadiazol-2-ones and -thiones are confirmed both analytically and chemically. Various equivalent and non-equivalent N-tert-butyldiacylhydrazines are conveniently synthesized from the reaction of tert-butylhydrazine hydrochloride in the presence of i-Pr₂NEt, with acid chloride #1 followed by subsequent treatment with acid chloride #2. Both the syntheses of 3,5-disubstituted-3H-[1,3,4]-oxadiazol-2-ones and -thiones, as well as N-tert-butyldiacylhydrazines, are easily performed on multigram scales.

cyclization - heterocycles - regioselectivity - hydrazine - phosgene

References

<A NAME="RM02201SS-1">1</A>

Tebufenozide (1a) is commercially available.

<A NAME="RM02201SS-2A">2a</A> Lidert Z, Le DP, Hormann RE, and Opie TR. inventors; US Patent  5530028. 

<A NAME="RM02201SS-3A">3a</A> James WNJr, and Aller HE. inventors; US Patent  5358966. 

<A NAME="RM02201SS-4">4</A> Thomson WT. Agricultural Chemicals, Book 1, Insecticides   Thomson Publications; Fresno, CA: 1998.  14th ed.. p.142-144  

<A NAME="RM02201SS-5A">5a</A> Huang LJ. Kuo SC. Wang JP. Ishii K. Nakamura H. Chem. Pharm. Bull.  1994,  41:  2036 

<A NAME="RM02201SS-5B">5b</A> Hazarika J. Kataky JCS. Ind. J. Heterocycl. Chem.  1997,  7:  47 

<A NAME="RM02201SS-5C">5c</A> Musser JH. Brown RE. Loev B. Bailey K. Jones H. Kahen R. Huang F. Khandwala A. Leibowitz M. J. Med. Chem.  1984,  27:  121 

<A NAME="RM02201SS-5D">5d</A> Khandwala A. Coutts S. Dally-Meade V. Jariwala N. Musser J. Brown R. Jones H. Loev B. Weinryb I. Biochem. Pharmacol.  1983,  32:  3325 

<A NAME="RM02201SS-5E">5e</A> Singh H. Yadav LDS. Bhattacharya BK. J. Ind. Chem. Soc.  1980,  57:  1006 

<A NAME="RM02201SS-5F">5f</A> Meyer RF. Cummings BL. J. Heterocycl. Chem.  1964,  1:  186 

<A NAME="RM02201SS-6A">6a</A> Squillacote M. Felippis JD. J. Org. Chem.  1994,  59:  3564 

<A NAME="RM02201SS-6B">6b</A> Saegusa Y. Nakamura S. Chau N. Iwakura Y. J. Polym. Sci.  1983,  21:  637 

<A NAME="RM02201SS-7">7</A> Gogoi PC. Kataky JCS. Heterocycles  1991,  32:  237 

<A NAME="RM02201SS-8">8</A>

We decided to further chemically validate the structure of 4a utilizing Gogoi’s method [7] for the synthesis of 3,5-disubsti-tuted-3H-[1,3,4]-oxadiazol-2-ones. We synthesized N’-(3,5-dimethylbenzoyl)hydrazinecarboxylic acid ethyl ester from the reaction of a CH₂Cl₂ solution of ethyl carbazate with 3,5-dimethylbenzoyl chloride in the presence of i-Pr₂NEt. Reaction of N’-(3,5-dimethylbenzoyl)hydrazinecarboxylic acid ethyl ester with POCl₃ afforded 5-(3,5-dimethylphenyl)-3H-[1,3,4]-oxadiazol-2-one (7), which was analytically identical to compound 7 synthesized via Scheme [2] (Table [2] ). Benzoylation of 7 with 4-ethylbenzoyl chloride afforded 5-(3,5-dimethylphenyl)-3-(4-ethylbenozyl)-3H-[1,3,4]-oxadiazol-2-one (4a), which was identical in all respects to 4a synthesized via our phosgene/N-tert-butyldiacylhydrazine route.

<A NAME="RM02201SS-9A">9a</A> Kelley MJ, and Budenz AM. inventors; US Patent  5675037.